Clinical trial
Evaluation of Damaging Factors to Endothelial Glycocalyx During On-pump Coronary Artery Bypass Surgery Using Syndecan-1 Biomarker.
NCT03491163 is registered in ClinicalTrials.gov with Lithuanian University of Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Damaging Factors to Endothelial Glycocalyx During On-pump Coronary Artery Bypass Surgery Using Syndecan-1 Biomarker.
- Lead sponsor
- Lithuanian University of Health Sciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 29, 2018
- Completion date
- October 30, 2020
- Enrollment
- 147 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart; surgery, heart, functional disturbance as result